BCYC - Bicycle Therapeutics EPS beats by $0.03 misses on revenue November, 04 2021 07:32 AM Bicycle Therapeutics plc Bicycle Therapeutics (NASDAQ:BCYC): Q3 GAAP EPS of -$0.59 beats by $0.03. Revenue of $4.33M (+12.8% Y/Y) misses by $1.42M. Press Release For further details see: Bicycle Therapeutics EPS beats by $0.03, misses on revenue